Intriguingly, XMU-MP-1 also restored Wnt signaling in the STZ-induced AD rat model [15], suggesting that its therapeutic effects may involve reactivation of both β-catenin and YAP transcriptional programs. The gene discussed is YAP1; the disease is Alzheimer disease.